Doctors' Health Fund

  eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Healthcare

Outcome of critically ill patients undergoing interhospital transfer

Graeme J Duke and John V Green

MJA 2001; 174: 122-125

Abstract - Methods - Results - Discussion - Acknowledgement - References - Authors' details

Register to be notified of new articles by e-mail - Current contents list - More articles on Administration and health services


Abstract

Objective: To quantify the morbidity and mortality associated with acute interhospital transfer of critically ill patients requiring intensive care (ICU) services.
Design: Three-year (1 July 1996 - 30 June 1999) retrospective case-control study based on review of patients' medical records.
Setting: Metropolitan hospitals in Melbourne, Victoria.
Participants: 73 (of 75) consecutive, critically ill patients from one metropolitan teaching hospital who were transferred to other hospitals because ICU services were not available.
Outcome measures: Primary endpoints included inhospital mortality and length of stay in ICU and hospital. Secondary endpoints included time from study entry to ICU admission and the change in predicted mortality risk after resuscitation and transfer to ICU (inter- or intrahospital transfer).
Results: The Transfer Group experienced a significant delay in admission to ICU (5.0 [4.0-6.0] v 3.0 [2.0-5.5] hours; P = 0.001), and a longer stay in ICU (48 [33-111] v 44 [25-78] hours; P = 0.04), and hospital (10 [3-14] v 6 [3-13] days; P = 0.02). Hospital mortality in the Transfer Group (24.7%) was not statistically different from that in the Control Group (17.8%; P = 0.41; OR, 1.5; 95% CI, 0.68-3.4).
Conclusion: Acute interhospital transfer is associated with a delay in ICU admission and a longer stay in ICU and hospital, but no statistically significant difference in mortality. A study of over 300 patient transfers would be required to clarify the morbidity and mortality risk of acute interhospital transfer.

Acute interhospital transfer of critically ill patients carries potential risks, including complications during transfer and delay in providing definitive care. There are two categories of acute interhospital transfer.

Category A: The primary (sending) hospital is unable to provide the expertise, diagnostic services or therapeutic procedures required by a patient (eg, transfer of a patient with extensive burns to a hospital with specialised treatment facilities for burns); and

Category B: The primary hospital is temporarily unable to provide intensive care unit (ICU) services for a patient because of resource limitations (eg, lack of ICU beds).

Measuring the impact of transfer risk on patient outcomes is complex. Reports without control data suggest that acute interhospital transfer increases both morbidity1,2 and mortality,3 but there are many confounding variables that influence outcome (eg, severity of illness, extent of resuscitation, and the expertise available before and during transfer). To our knowledge, no comparative outcome study of critically ill patients undergoing acute interhospital transfer has been published.

A randomised trial of Category A transfer would be complicated by the difficulty of finding a clinically and ethically appropriate control group. An alternative is to compare outcomes of patients undergoing Category B transfer with outcomes of matched patients not transferred. Both these groups of patients are resuscitated and managed with similar expertise and support. It is therefore possible to reduce bias from some of the confounding variables, and to identify a suitable control group.

We performed a retrospective case-control comparison of outcomes in critically ill adult patients undergoing Category B transfer. We hypothesised that acute interhospital transfer increases morbidity and mortality and sought to answer four questions: Does acute interhospital transfer of critically ill patients

  • delay admission to an ICU;

  • increase severity of illness before admission;

  • increase ICU and hospital length of stay; and

  • increase mortality?

Methods

The primary hospital was the Northern Hospital, a Melbourne metropolitan teaching hospital providing all acute-care health services (except cardiac surgery and organ transplantation).*  

Transfer Group

All adult patients requiring intensive care services between 1 July 1996 and 30 June 1999 were entered in the study if they

  • were deemed by the intensivist on-duty to require intensive care services;

  • were transferred to a (public or private) metropolitan hospital for those services; and

  • received diagnostic and therapeutic interventions that could otherwise have been provided at the primary hospital.

All patients were transferred by road ambulance with an experienced medical escort from the primary hospital.

Patients were excluded if they were transferred with the intention of receiving services not available at the primary hospital (Category A transfer), or if insufficient data were available.

Control Group

Control patients were selected from patients admitted to the ICU of the primary hospital, who did not undergo acute interhospital transfer at any time during the study period. Matching of Control Group patients with patients in the Transfer Group was undertaken according to a hierarchy of criteria deemed most likely to influence patient outcome (Box 1). Due to difficulties matching for all criteria, priority was placed on the first four. Matching was undertaken by one author (J V G), who was blinded to the identity and outcome of the patients.

Endpoints

These included inhospital mortality, time from study entry to ICU admission, length of stay in ICU and hospital, and the change in predicted mortality risk after resuscitation and transfer to ICU (Box 2).

Patient data (Box 2)

Patients' data recorded prospectively in the medical records at all the hospitals involved were reviewed retrospecively by one investigator (G J D). Physiological and laboratory data were used to calculate predicted mortality risk (pm) at three time points (t1, t2 and t3; Box 2), as an index of illness severity, using the Acute Physiology and Chronic Health Evaluation (APACHE) II method.4 Length of stay and pm were chosen as surrogate markers of patient morbidity.

Because of the broad range of pm within the Transfer Group (0.01-0.86), we also undertook a post-hoc analysis of the change in pm (Delta symbolpm) during each interval as a measure of the change in physiological status. Since pm is an indicator of illness severity, and since calculations were performed before and after resuscitation and transfer, the physiological impact of resuscitation ([pm at t2] - [pm at t1]) and of transfer ([pm at t3] - [pm at t2]) was quantified.

Statistical analysis

Graph-Pad PRISM statistical package was used for data analysis.5 We used Fisher's exact test to compare group mortality. Non-parametric tests were used to compare length of stay in ICU and in hospital, and for intergroup comparison of pm and Delta symbolm (Mann-Whitney; P < 0.05). Wilcoxon signed rank test was used for post-hoc intragroup comparisons of Delta symbolm (P < 0.01). Data are presented as median (interquartile range) unless otherwise indicated.

Based on studies without control data,3,6 which showed a doubling of mortality after acute interhospital transfer and a Control Group mortality of 18%, we calculated that a sample size of at least 50 patients would be required (Alpha symbol = 0.05, Beta symbol = 0.80.)

Ethical approval

Ethics committee approval was obtained from each of the 14 hospitals involved.


Results

During the 36 months, 1470 patients required intensive care services at the primary hospital. Of these, 1338 (91%) were admitted and were the source of the Control Group patients. Of the 132 (9%) patients not admitted to the primary hospital ICU, 75 consecutive patients (5.1%) underwent a Category B transfer (Transfer Group), 35 (2.4%) were managed elsewhere within the same hospital (eg, general ward) and 22 (1.5%) were transferred for services not available at the primary hospital (Category A transfers). The last two groups were excluded from the study. Two eligible patients in the Transfer Group were excluded because insufficient data were available from the receiving hospitals, leaving 73 patients.

The destinations of the transferred patients were determined by the proximity of the other hospitals and the bed availability. Sixty-four patients were transferred to nine public hospitals, and 11 patients were transferred to five private hospitals (eight of these patients had no private health insurance, but no public hospital ICU bed was available within the metropolitan region at that time). The reasons for transfer were closure of beds in 61 patients (84%), and equipment problems, all beds occupied and patient request in six, five and one patient, respectively.

Demographic and other data for the Transfer and Control group patients, as well as the accuracy of case-control matching, are summarised in Box 3, and the diagnostic categories of the patients are shown in Box 4.

Both groups had a high mortality risk at the time of study entry (commencement of resuscitation -- pm at t1) and immediately before transfer (pm at t2) (Box 5). Post-hoc analysis of Delta symbolpm revealed a significantly greater fall in pm during resuscitation and during transfer to ICU in the Control Group patients (P < 0.01). Thirty-seven patients (51%) undergoing acute interhospital transfer experienced a rise in pm (t3), compared with only 20 (27%) of the control group (P = 0.006).

No deaths occurred during transfer. The higher observed mortality in the Transfer Group (Box 4) was not statistically different from that in the Control Group (odds ratio [OR], 1.5; 95% CI, 0.68-3.4). The diagnostic group (Box 4) and severity of illness (pm) were the most important univariate factors associated with outcome.

Acute interhospital transfer was associated with a significant delay in ICU admission (Box 5), although some of the control patients also experienced admission delays (range, 0.5-9.5 hours). The Transfer Group was also found to have a significantly prolonged length of stay in ICU and hospital when compared with the Control Group. These length-of-stay increases were independent of outcome, diagnosis, age and hospital destination.


Discussion

We found that critically ill patients undergoing acute interhospital transfer experience a delay in admission to ICU, and a longer length of stay in ICU and hospital. However, there was no significant difference in hospital mortality between the two groups, and there were no deaths during transfer.

As indicated by their primary diagnoses, need for life-support and high mortality risk, all patients in our study were critically ill at the time of study entry. The apparent safety of acute interhospital transfer is likely to be the combined result of factors such as resuscitation and stabilisation before transfer; the use of staffed and equipped ambulance vehicles; the provision of intensive care medical expertise and monitoring before, during and after transfer; and triage to appropriate hospitals.7

Why did the Transfer Group have an increased length of stay? The rise in pm after acute interhospital transfer in 37 patients (51%) suggests that it may increase morbidity in some patients. Other researchers have also reported adverse physiological effects during transfer of critically ill patients,1,2 and a higher mortality in patients admitted after interhospital transfer.3,6

Delay in ICU admission inevitably delays diagnostic and therapeutic procedures. The increased sedation and analgesia to ensure patient safety and comfort during interhospital transfer may prolong recovery time. The slower rate of fall of pm in the Transfer Group is consistent with this premise. Patient management and discharge practices may vary between institutions and thus increase length of stay independent of diagnosis and patient origin.

Our study has several important limitations. Retrospective chart analysis carries potential for observer bias and systematic error. We attempted to minimise this by sampling data at predetermined fixed time points and using the same data collector. Patient selection was unavoidably biased because the Transfer Group constituted a heterogeneous and non-randomised group of critically ill patients. Because of the small number of subjects in some diagnostic categories, the matching of Control Group patients with patients in the Transfer Group was not perfect, but we attempted to optimise matching by using a criteria hierarchy. The Control Group patients had a greater median pm at study entry, and some experienced a clinically significant delay in ICU admission, both factors which may have reduced the outcome difference between the groups.

Although the APACHE-II scoring system4 has been used in the prehospital setting,3,8 it assumes patients are in an intensive care environment receiving optimal therapy, and therefore it may not be a valid tool for use outside an ICU. However, this potential systematic error applied equally to both groups.

The study size had insufficient power to establish a difference in mortality. If the observed difference in outcome is clinically significant it would require a sample size of over 300 transfers to exclude a type II statistical error. A trial of sufficient power could be achieved with a 12-month multicentre study of all Category B transfers within metropolitan Melbourne. During 1998-1999, 369 critically ill adults (3.5% of metropolitan adult intensive care admissions) underwent a Category B transfer (Department of Human Services, Critical Care Inter-Hospital Transfer Monitoring and Advisory Group, personal communication).

At best, our results indicate that acute interhospital transfer does not affect hospital outcome; at worst, they suggest that it may adversely affect the outcome of one in every 25 critically ill patients transferred. Extrapolating our results to the metropolitan region, acute interhospital transfer may adversely affect the outcome of 15 patients (95% CI, 0-48) per annum, and require an additional 1100 hospital bed-days (95% CI, 960-1266 days) per annum -- half in ICU, where the primary resource limitation exists.9,10



Acknowledgement

We would like to thank Professor B Jackson and Dr P Cranswick for their constructive criticism of the manuscript.


References

  1. Waddell G, Scott PDR, Lees NW, Ledingham IM. Effects of ambulance transport in critically ill patients. BMJ 1975; 1: 386-389.
  2. Karipis H, Scheinkestel CD, Tuxen DV, et al. Safety of transportation of critically ill patients. Anaesth Intensive Care 1993; 21: A7111.
  3. Bristow P, Brown D, Lee A, Buist M. Transfer of severely ill patients. Anaesth Intensive Care 1995; 23: A399.
  4. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
  5. GraphPad PRISM, version 1. San Diego: GraphPad Software Inc, 1998.
  6. Metcalf A, McPherson K. Study of provision of intensive care in England, 1993. London: School of Hygiene and Tropical Medicine, 1995.
  7. Faculty of Intensive Care, Australian and New Zealand College of Anaesthetists and Australasian College of Emergency Medicine. Minimum standards for transport of the critically ill (IC-10). Melbourne: Australian and New Zealand College of Anaesthetists and Australasian College of Emergency Medicine, 1996.
  8. Bion JF, Edlin SA, Ramsay G, et al. Validation of a prognostic score in critically ill patients undergoing transport. BMJ 1985; 291: 432-434.
  9. Acute Health Services Branch, Department of Health and Community Services Review of emergency and critical care services in Victoria. Melbourne: Department of Health and Community Services, 1994.
  10. Acute Health Division, Department of Human Services. Review of intensive care in Victoria [Phase 1 report]. Melbourne: Department of Human Services, 1997.

(Received 3 Apr, accepted 15 Sep, 2000)



Authors' details

Intensive Care Department, The Northern Hospital, Melbourne, VIC.
Graeme J Duke, MB BS, FFICANZCA, Director;
John V Green, MB BS, FFICANZCA, Staff Specialist.

Reprints will not be available from the authors.
Correspondence: Dr G J Duke, Intensive Care Department, The Northern Hospital, 185 Cooper Street, Epping, VIC 3076.
graeme.dukeATnh.org.au

©MJA 2001

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  


Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".

<URL: http://www.mja.com.au/> © 2001 Medical Journal of Australia.
 

1: Criteria for matching Control Group patients with Transfer Group patients
  1. Discharge diagnosis (APACHE-III diagnostic code)
  2. Need for mechanical ventilation on admission to Intensive Care Unit
  3. Glasgow coma score (GCS) at t1 - within 2 points
  4. Predicted mortality (pm; APACHE-II methodology4) at t1 - within 10%
  5. Age - within 10 years
  6. Sex
  7. Source of initial referral (emergency ward, inpatient ward, operating theatre)
  8. Date of admission - within 12 months
  9. Time (t1): day (8:00 to 18:00) or night

APACHE=Acute Physiology and Chronic Health Evaluation. Time, t1=study entry at commencement of resuscitation.
Back to text
 

2: Patient dataset

  • Demographic information, including age, sex, and postcode of residence
  • Relevant medical data, including past history and final diagnosis
  • Dates and times of primary admission, initial referral, interhospital transfer, ICU discharge and hospital discharge
  • Referral source
  • Treatment and personnel required during transfer
  • Interventions required (at both hospitals)
  • Data for APACHE II predicted mortality (pm) score4*
    Physiological data: blood pressure, heart rate, respiratory rate, Glasgow coma score, urine output
    Pathological data: haematocrit and total white cell count; serum levels of sodium, potassium, creatinine, urea, albumin, and glucose; and arterial pH and blood gas analysis
    Clinical data: age, diagnosis, use of mechanical ventilation, presence of acute renal failure, chronic health status
  • Time of APACHE II predicted mortality (pm) calculations (see time line)
    t1= study entry at commencement of resuscitation.
    t2= before transfer to ICU, after initial resuscitation.
    t3= on arrival in ICU after transfer.
 
Time line
 

APACHE=Acute Physiology and Chronic Health Evaluation.
*Formula for pm score:
logn(pm/12pm)=-3.517+0.146 (k1+k2+k3)+k4+k5, where
k1=a variable score based on physiological and pathological data;
k2=a variable weighting for age;
k3=a variable weighting for chronic health status;
k4=a constant weighting for emergency surgical patients; and
k5=a variable weighting for principal diagnostic category.
Back to text
 
3: Comparison of patient data (Transfer Group v Control Group - data are median and interquartile range unless indicated otherwise) and percentage matching between the two groups
 
Criterion Transfer Group Control Group Percentage matching*

Diagnostic group (see Box 4) (see Box 4) 100%
Need for mechanical ventilation
   (no [%] of patients) 51 (73%) 51 (73%) 100%
Predicted mortality at start
   of resuscitation (pm at t1) 0.30 (0.09-0.62) 0.37 (0.09-0.60) 69%
GCS: patients with neurological
   problems (n=39) 7 (6-9) 7 (6-8) 100%
GCS: all patients (n=73) 9 (6-14) 8 (6-12) 96%
Age (years) 54.8 (36.4-67.2) 57.4 (38.0-70.4) 67%
Source of referral (no [%] of
   patients)
61 (83%) from ED 59 (81%) from ED 79%
Sex ratio (no. of men:women) 39:34 46:27 78%
Date of admission (baseline) 3 (1-15) months 75%
Time (t1) (8:00-18:00)
   (no. [%] of patients) 28 (38%) 36 (49%) 60%

*Percentage of Control Group patients matched according to criteria given in Box 1. GCS=Glasgow Coma Score. ED=emergency department.
Back to text
 
4: Diagnostic categories and inhospital mortality
    Deaths
   
Discharge diagnosis No. (%) patients Transfer Group Control Group

Trauma
Drug overdose
Cardiac arrest
Cardiogenic shock
Exacerbation of COPD
Status asthmaticus
Pneumonia
Cerebrovascular coma
Metabolic coma
Neurological conditions
Gastrointestinal conditions
Septicaemia
Malignancy
Aortic aneurysm
Total
12 (16%)
11 (15%)
8 (11%)
7 (10%)
5 (7%)
3 (4%)
4 (5%)
4 (5%)
4 (5%)
4 (5%)
4 (5%)
4 (5%)
2 (3%)
1 (1%)
73 (100%)
0
0
6
0
0
0
2
2
1
1
2
3
1
0
18 (24.7%)
0
0
5
1
0
0
1
1
2
1
1
1
0
0
13 (17.8%)
95% CI 11-25 7-20

COPD=Chronic obstructive pulmonary disease.
Back to text
 

5: Acute Physiology and Chronic Health Evaluation (APACHE) II predicted risk of death (pm; median and interquartile range) and outcomes

  Transfer Group Control Group P*

APACHE II risk of death
pm at t1
   (at study entry) 0.30 (0.09-0.62) 0.37 (0.09-0.60) 0.87
pm at t2
   (before transfer) 0.24 (0.06-0.40) 0.25 (0.06-0.47) 0.69
pm at t3
   (at ICU entry) 0.21 (0.06-0.46) 0.16 (0.04-0.46) 0.63
Outcomes
Admission delay
   (t3 - t1; hours) 5.0 (4.0-6.0) 3.0 (2.0-5.5) 0.001
Length of stay
    ICU (hours) 48 (33-111) 44 (25-78) 0.04
   Hospital (days) 10 (3-14) 6 (3-13) 0.02
Mortality (no. of patients) 18 (95% CI, 11-25) 13 (95% CI, 7-20) 0.41

ICU=Intensive Care Unit. * Mann-Whitney test.
Back to text